scispace - formally typeset
E

Eugene A. Sprague

Researcher at University of Texas Health Science Center at San Antonio

Publications -  105
Citations -  6288

Eugene A. Sprague is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Endothelial stem cell & Stent. The author has an hindex of 39, co-authored 105 publications receiving 6083 citations. Previous affiliations of Eugene A. Sprague include Georgia Institute of Technology & University of Texas System.

Papers
More filters
Patent

Valvular prostheses having metal or pseudometallic construction and methods of manufacture

TL;DR: In this article, the authors describe improvements in prosthetic cardiac and venous valves and implantable medical devices having moveable septa. And they describe a set of methods for percutaneous delivery of the devices.
Journal ArticleDOI

Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin.

TL;DR: Results suggest fluid flow shear stress induces the translocation of Cx43 to the membrane surface and that unapposed hemichannels formed by Cx 43 serve as a novel portal for the release of PGE2 in response to mechanical strain.
Journal ArticleDOI

The pathogenesis of atherosclerosis: An overview

TL;DR: The atherogenic cascades so described conceptually represent arterial inflammatory and healing processes occurring in a hyperlipidemic environment.
Patent

Endoluminal device exhibiting improved endothelialization and method of manufacture thereof

TL;DR: An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution is described in this article.
Journal ArticleDOI

The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography

TL;DR: Plasma cortisol was second only to serum cholesterol as a discriminator in the authors' patient population between diseased and non-diseased patients and a significant correlation between plasma cortisol and cholesterol, blood pressure, and smoking- the three cardinal risk factors for CAD.